CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net loss $ (167,731) $ (163,458) $ (89,195)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation expense 33,665 41,271 27,528
Depreciation and amortization expense 5,691 2,995 1,263
Change in fair value of preferred stock warrant liability     2,187
Amortization (accretion) of premium (discount) on investments 266 (2,320) (329)
Loss on disposal of property and equipment   335  
Non-cash interest expense 349 289 86
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 992 2,655 (9,037)
Operating lease, right-of-use-asset 5,539 4,991  
Other assets 46 2 (74)
Accounts payable (1,369) (1,037) 4,938
Accrued expenses and other current liabilities (96) 6,107 4,307
Other long-term liabilities 283 396 (15)
Operating lease liabilities (5,283) (2,670)  
Net cash used in operating activities (127,648) (110,444) (58,341)
Cash flows from investing activities:      
Purchases of property, plant and equipment (5,497) (40,657) (14,952)
Purchases of investments (122,671) (319,133) (160,972)
Sales and maturities of investments 228,600 227,155 64,285
Net cash provided by (used in) investing activities 100,432 (132,635) (111,639)
Cash flows from financing activities:      
Proceeds from issuance of convertible preferred stock, net of issuance costs     100,986
Proceeds from initial public offering of common stock, net of commissions and underwriting discounts     257,866
Payments of initial public offering costs     (3,548)
Proceeds from repayment of promissory note     246
Payments of debt issuance costs     (285)
Repurchase of unvested restricted common stock   (122)  
Proceeds from borrowings under loan and security agreement 25,000 25,000 25,000
Payment of long-term debt     (5,500)
Proceeds from issuance of common stock upon exercise of stock options 1,484 2,413 64
Net cash provided by financing activities 26,484 27,291 374,829
Net decrease in cash, cash equivalents and restricted cash (732) (215,788) 204,849
Cash, cash equivalents and restricted cash at beginning of period 93,633 309,421 104,572
Cash, cash equivalents and restricted cash at end of period 92,901 93,633 309,421
Supplemental cash flow information:      
Cash paid for interest, net of interest capitalized 3,822 2,961 385
Cash paid for leases 8,486 5,375  
Lease assets obtained in exchange for new operating lease liabilities 496 49,799  
Lease asset derecognized upon lease cancellation 982    
Supplemental disclosure of non-cash investing and financing information:      
Purchases of property, plant and equipment included in accounts payable or accrued expenses $ 317 3,095 1,550
Amounts capitalized under build-to-suit lease transaction     45,142
Proceeds from issuance of common stock upon exercise of stock options in other current assets   $ 32  
Reclassification of warrant liability to additional paid-in capital     3,053
Conversion of preferred stock to common stock upon closing of the initial public offering     240,776
Debt issuance costs included in accounts payable and accrued expenses     $ 489